✦ LIBER ✦

Long-Term Clinical Outcome of Thin-Strut Cobalt-Chromium Stents in the Drug-Eluting Stent Era: Results of the COBALT (Comparison of Bare-Metal Stents in All-Comers’ Lesion Treatment) Registry

✍ Scribed by MOHAMED ABDEL-WAHAB; RALPH TOELG; GUIDO KASSNER; LOTHAR KLATT; MOHAMMAD A. SHERIF; VOLKER GEIST; GERT RICHARDT

Book ID: 109218107
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 931 KB
Volume: 24
Category: Article
ISSN: 0896-4327
DOI: 10.1111/j.1540-8183.2011.00672.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome of patients treated by a novel t

Outcome of patients treated by a novel thin-strut cobalt-chromium stent in the drug-eluting stent era: Results of the SKICE (Skylor in real world practice) registry

✍ Francesco Burzotta; Carlo Trani; Daniel Todaro; Mario Attilio Mazzari; Italo Por 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB 👁 2 views

Long-term outcomes of drug-eluting stent

Long-term outcomes of drug-eluting stents versus bare-metal stents in saphenous vein graft disease: Results from the Prairie “Real World” Stent Registry

✍ Nilesh J. Goswami; Matthew Gaffigan; Gadiel Berrio; Anna L. Plessa; Amanda M. Pf 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 3 views

Comparing long-term outcomes between dru

Comparing long-term outcomes between drug-eluting and bare-metal stents in the treatment of cardiac allograft vasculopathy

✍ Tonga Nfor; Imran Ansaarie; Anjan Gupta; Tanvir Bajwa; Suhail Allaqaband 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views

Long-Term Clinical Outcomes and Stent Th

Long-Term Clinical Outcomes and Stent Thrombosis of Sirolimus-Eluting Versus Bare Metal Stents in Patients with End-Stage Renal Disease: Results of Korean Multicenter Angioplasty Team (KOMATE) Registry

✍ BYEONG-KEUK KIM; SEUNGJIN OH; DONG WOON JEON; JOO YOUNG YANG; JUNG-SUN KIM; SUNG 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 211 KB

Long-Term Clinical and Economic Analysis

Long-Term Clinical and Economic Analysis of the Endeavor Drug-Eluting Stent Versus the Driver Bare-Metal Stent: 4-Year Results From the ENDEAVOR II Trial (Randomized Controlled Trial to Evaluate the Safety and Efficacy of the Medtronic AVE ABT-578 Eluting Driver Coronary Stent in De Novo Native Coronary Artery Lesions)

✍ Eric L. Eisenstein; William Wijns; Jean Fajadet; Laura Mauri; Rex Edwards; Patri 📂 Article 📅 2009 🏛 American College of Cardiology 🌐 English ⚖ 364 KB